Fresenius Medical Care

XL Construction Appoints Carol McKenna to Vice President, People

Retrieved on: 
Tuesday, November 15, 2022
People, DE, Society for Human Resource Management, McKenna, Acquisition, BD, GRD, Organization, Leadership, University, Senior, San Francisco Bay Area, Acceleration, John F. Kennedy University, Health, San Francisco State University, Education, Multimedia, HR, Program, Fresenius Medical Care, Certification, Organization development, SHRM, XL, Management

MILPITAS, Calif., Nov. 15, 2022 /PRNewswire/ -- XL Construction, a leading Northern California builder, has appointed Carol McKenna, a 20+ year human resources veteran, as Vice President, People, in its Organizational Development Group.

Key Points: 
  • MILPITAS, Calif., Nov. 15, 2022 /PRNewswire/ -- XL Construction, a leading Northern California builder, has appointed Carol McKenna, a 20+ year human resources veteran, as Vice President, People, in its Organizational Development Group.
  • In the newly created role, McKenna will report to Alan Laurlund, XL's Senior Vice President of Organizational Development.
  • Prior to joining XL, McKenna developed and led successful global HR teams at Fresenius Medical Care based in Concord, Calif., most recently as Vice President, Human Resources Global R&D, for the 100,000+ employee organization.
  • XL Construction is a leading general contractor whose mission is to "build to improve lives."

Hemodialysis And Peritoneal Dialysis Global Market Report 2022: Rising Prevalence of Kidney Disease Boosts Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 9, 2022
Medical Devices, Health, Dialysis, Hospital, Prevalence, Center, Fresenius Medical Care, Peritoneal dialysis, AWAK, Chronic kidney disease, Centers for Disease Control and Prevention timeline, Kidney, Electrolyte, Disorder, Fistula, Asia-Pacific, Growth, Blood, PD, Medical device

The "Hemodialysis And Peritoneal Dialysis Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis And Peritoneal Dialysis Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The main types of hemodialysis and peritoneal dialysis are hemodialyses, short-term catheters, chronic catheters, graft, fistula, and peritoneal dialysis.
  • The growing prevalence of kidney diseases is expected to propel the growth of the hemodialysis and peritoneal dialysis market going forward.
  • Therefore, the growing prevalence of kidney diseases is driving the hemodialysis and peritoneal dialysis market.

Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting

Retrieved on: 
Monday, November 7, 2022
American Heart Association, Infection, Blood, Fresenius Medical Care, Polytetrafluoroethylene, Amputation, FDA, RCA, FACS, Annual report, Moyamoya disease, Partnership, Technology, SEC, CABG, Invention, Company, Ageing, Food, Saphenous, GLOBE, BLA, Injury, Forward-looking statement, HAV, Patient, Food and Drug Administration Amendments Act of 2007, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Coronary artery bypass surgery, Terminology, COVID-19, Intention, Regenerative medicine, HUMA, Biological engineering, Plague, AHA, Swelling, Tissue, Fast track (FDA), Patent, AV, Cell, Safety, Disease, Trauma, Nasdaq, SVG, Longevity, CT, Medicine, Computed tomography angiography, Surgeon, Vibration, Pharmaceutical industry, Medical imaging, Defense

DURHAM, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues and advanced tissue constructs and organ systems at commercial scale, announced updated six-month results of the HAV in a baboon CABG model. These data were presented in two oral presentations at the annual American Heart Association (AHA) Scientific Sessions meeting, held in Chicago, Illinois from November 5-7, 2022.

Key Points: 
  • These data were presented in two oral presentations at the annual American Heart Association (AHA) Scientific Sessions meeting, held in Chicago, Illinois from November 5-7, 2022.
  • The data presented consisted of three baboons, aged eight to 10 years, in which the HAV was implanted as an aorta-to-right coronary artery (RCA) graft.
  • Coronary artery bypass grafting is one of the most common surgical procedures in the U.S.
  • Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications.

Healthcare Workers at 13 Dialysis Clinics Across California File for Union Elections

Retrieved on: 
Thursday, November 3, 2022
Amazon, GLOBE, Industry, Health, SEIU, Fresenius Medical Care, Starbucks, SEIU United Healthcare Workers West, Kidney failure, Patient, Dialysis, Social, Healthcare

OAKLAND, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Nearly 300 healthcare workers at 13 dialysis clinics across the state have filed for elections to join SEIU-United Healthcare Workers West to improve working conditions, staffing, patient care, and wages at their facilities.

Key Points: 
  • OAKLAND, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Nearly 300 healthcare workers at 13 dialysis clinics across the state have filed for elections to join SEIU-United Healthcare Workers West to improve working conditions, staffing, patient care, and wages at their facilities.
  • Eight of the 13 dialysis clinics where workers filed for union elections are owned by Fresenius Medical Care and five by Satellite Healthcare.
  • These 13 dialysis clinics include facilities in San Francisco, the East Bay Area, San Diego County, the greater San Jose region, and Camarillo.
  • Dialysis workers have been working with SEIU-UHW members for six years to improve patient protections and to hold the industry accountable to workers and patients alike.

Global Dialysis Market Report 2022: Preference for Dialysis Over Transplants Driving Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 4, 2022
General Health, Health, Medical Devices, Co-production (public services), Awareness, Equipment, Kidney, Dialysis, Fresenius Medical Care, Growth, CAGR, Product-service system, Product, Chronic kidney disease, Population, Ageing, Incidence, Hypertension, Waste, Quality of life, Kidney failure, COVID-19, Stroke, Arthritis, US, Cardiovascular disease, Prevalence, ESRD, Diabetes, Peritoneal dialysis, Blood, Pharmaceutical industry, Medical device, Health insurance, Patient

The global dialysis market was valued at US$98.30 billion in 2021.

Key Points: 
  • The global dialysis market was valued at US$98.30 billion in 2021.
  • By End-User: The report provides an analysis of the market based on end-user: In-Center Dialysis and Home Dialysis.
  • The aging population is one of the main drivers of growth in the global dialysis market.
  • The key players in the global dialysis market are:
    Fresenius Medical Care AG & Co. KGaA

Connections Health Solutions Announces Laura Buckley as Chief Operating Officer

Retrieved on: 
Thursday, November 3, 2022
Growth, Connections, Mental health, Patient, Geography, Company, Fresenius Medical Care, WellCare, Kidney, COO, LLC, Family, Observation, Hospital, Medicaid

PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Connections Health Solutions , the leading innovator in immediate-access behavioral health crisis care, today announced the addition of Laura Buckley as Chief Operating Officer.

Key Points: 
  • PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Connections Health Solutions , the leading innovator in immediate-access behavioral health crisis care, today announced the addition of Laura Buckley as Chief Operating Officer.
  • "We are thrilled to have Laura join Connections and help lead the team into a period of exciting growth," said Connections Health Solutions' CEO Colin LeClair.
  • Connections now provides immediate-access behavioral health crisis care in Arizona and Montana and has expanded services to include mobile crisis, behavioral health urgent care clinics, observation and treatment units, behavioral health subacute units, and recovery outpatient programs.
  • Connections Health Solutions, LLC is the leading innovator of behavioral health crisis care.

Fresenius Medical Care North America Announces FDA Clearance of New Heat Purification System for Hemodialysis Water with Industry-Leading Efficiency

Retrieved on: 
Thursday, November 3, 2022
Senior, ANSI, U.S. Securities and Exchange Commission, Regulation of tobacco by the U.S. Food and Drug Administration, FDA, Maintenance, Dialysis, Water, Disinfectant, Industry, Food, Water purification, View, Technology, Efficiency, Patient, Automation, Fresenius Medical Care, Safety, Multimedia, RO, Sewage, Medical device, Risk management

WALTHAM, Mass., Nov. 3, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group announced today that the U.S. Food and Drug Administration (FDA) has cleared the AquaA™ water system, one of the industry's most efficient water purification systems available for hemodialysis. The new system, from the nation's leading dialysis products company, uses advanced technology to optimize water and power usage with full heat disinfection, while being customizable to the unique needs of each dialysis center.

Key Points: 
  • The AquaA system uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from the water required for hemodialysis treatment.
  • Water and energy saving: AquaA minimizes water intake and leads the industry in efficiency with an up-to-85-percent water recovery rate.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

EQS-News: Heidelberger Druckmaschinen AG: Tania von der Goltz appointed CFO of Heidelberger Druckmaschinen AG

Retrieved on: 
Thursday, November 3, 2022
Financial Oversight and Management Board for Puerto Rico, Labour, CEO, RTÉ Executive Board, Time, Fresenius Medical Care, CFO, Board of directors, Supervisory board, Senior, Management, Pension fund, Cryptocurrency

She will succeed Marcus A. Wassenberg as of January 1, 2023

Key Points: 
  • She will succeed Marcus A. Wassenberg as of January 1, 2023
    At its meeting today, the Supervisory Board of Heidelberger Druckmaschinen AG(HEIDELBERG) appointed Tania von der Goltz as CFO with effect from January 01, 2023.
  • Tania von der Goltz thus succeeds Marcus A. Wassenberg, whose departure from the company had recently been announced.
  • Tania von der Goltz was most recently with Fresenius Medical Care as Senior VicePresident Global Financial Strategy, responsible for her company's global financialstrategy.
  • Image 1: The Supervisory Board of HEIDELBERG has appointed Tania von der Goltz as a full member of the Management Board and CFO with effect from January 1, 2023.

Fresenius Medical Care North America Upgrades Liberty Select Peritoneal Dialysis Cycler with New Connected Health Capabilities

Retrieved on: 
Wednesday, November 2, 2022
Ultrafiltration, Population, Color, Conference, Research, Patient, U.S. Securities and Exchange Commission, Dialysis, Program, Physician, Hospital, Use, Regulation of tobacco by the U.S. Food and Drug Administration, Fresenius Medical Care, Diagnosis, Sale, EHR, Adoption, West Midlands CARE Team, PD, Abstract, Review, Associate, FDA, Food, Health equity, Peritoneal dialysis, Contraindication, Quality of life, All rights reserved, LP, Medical device, Pharmaceutical industry, Longevity

WALTHAM, Mass., Nov. 2, 2022 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading dialysis products company, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance upgrading the company's Liberty® Select Cycler to enable remote therapy management with the Kinexus® Therapy Management Platform. This upgrade is designed to elevate the home therapy experience for peritoneal dialysis (PD) patients and clinicians.1

Key Points: 
  • Liberty Select with Kinexus is distributed by NxStage Medical, Inc., a subsidiary of Fresenius Medical Care.
  • Fresenius Medical Care, the triangle logo, Kinexus, Liberty Select, Liberty, and VersiPD are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

EQS-News: Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022

Retrieved on: 
Monday, October 31, 2022
Industry, Fresenius Medical Care, Life, Public expenditure, EVP, Service, Government, News, Growth, EDT, Income, COVID-19, New, Press release, EPS, Investment, Company, FMS, EUR, Frankfurt Stock Exchange, PDF, Patient, CET, Health Care Service Corporation, Outbreak Management Team, Dialysis, Nature, Provider, U.S. Securities and Exchange Commission, Mortality, Kidney, Critical care, FME, Senior management, Program, Infection, Disclosure, Health insurance, Risk management, Pharmaceutical industry, Film, Animal, Cryptocurrency, Security (finance), Health care, EMEA

The new company operates under the InterWell Health brand and will be fully consolidated by Fresenius Medical Care as the majority owner.

Key Points: 
  • The new company operates under the InterWell Health brand and will be fully consolidated by Fresenius Medical Care as the majority owner.
  • The impacts of Fresenius Medical Cares focused efforts to improve North American Health Care Services operations are delayed against the Companys previous assumptions.
  • Fresenius Medical Care carefully observes and assesses the development of infection rates in fall.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.